Liminatus Pharma, Inc.

LIMN
$0.17 (- $0.08 - 31.30%)
Last updated: 2026-05-24 06:49 UTC
LIMN Metrics
Exchange
🇺🇸 NASDAQ XNMS
Nasdaq/NMS (Global Market)United StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS53271X1081
CUSIP53271X108
Market Price0.17
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-0.16
Market Cap$19.2M
Book Value-0.06
Price to Book-11.607
Beta0.38
52w High33.66
52w Low0.61
Next Earnings DateN/A

Liminatus Pharma, Inc. trades under ticker LIMN on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US53271X1081, CUSIP 53271X108.

About the Company
Liminatus Pharma, Inc. operates as a pre-clinical stage biopharmaceutical company that develops novel cancer therapies. It is developing CD47, a high affinity humanized anti CD47 antibody that has the potential to translate into clinic for CD47 SIRPa blocking and restoring the anti-tumor function of innate immune cells without inducing hemagglutination or hemolysis. The company was founded in 2018 is based in LA Palma, California.
Price History